Antiviral Medications for Systemic Use – Framework Agreement for Supply of Products – Medicines for the Treatment of HIV/AIDS and Post-Exposure Treatment (2024-2025)
This framework agreement aims to establish subsequent contracts for the procurement of medicines for the treatment of individuals with HIV/AIDS and for post-exposure treatment (2024-2025). The specific medications include BICTEGRAVIR, EMTRICITABINE, and TENOFOVIR in dosages of 50 mg/200 mg/25 mg, as
AwardedHealthcare & MedicalRomaniaPublished 27 Aug 2025